Irinotecan – klinischer Fortschritt in der Second-line-Therapie des fortgeschrittenen Kolorektalkarzinoms

Publisher： Karger

E-ISSN： 2296-5262|23|6|28-31

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.6, 2004-11, pp. : 28-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Kombination mit Irinotecan – die Referenztherapie in der First-line-Therapie des fortgeschrittenen Kolorektalkarzinoms

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 32-34

Karger

Access to resources Recommend Favorite

Second-line-Therapie des Ovarialkarzinoms

Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. : 593-596

Karger

Access to resources Recommend Favorite

Docetaxel in der First- und Second-line-Therapie des Magenkarzinoms

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 40-42

Karger

Access to resources Recommend Favorite

Caelyx^® in der Therapie des fortgeschrittenen Ovarialkarzinoms

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 40-45

Karger

Access to resources Recommend Favorite

Neue Chemotherapeutika in der Therapie des fortgeschrittenen Magenkarzinoms

Oncology Research and Treatment, Vol. 26, Iss. 7, 2004-11 ,pp. : 54-59

Karger

Access to resources Recommend Favorite